Socioeconomic Costs of Chronic Kidney Disease: Evidence from Southwest Vietnam
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6
Abstract
ABSTRACT Introduction: Chronic Kidney Disease (CKD) has a high mortality in developing countries. This burden is increasing rapidly in Vietnam. The high cost of medication and haemodialysis are major barriers in the successful treatment of CKD. Aim: To determine from a societal perspective the complete cost associated with CKD. Materials and Methods: A cross-sectional study was conducted to estimate the total costs associated with the cost-of-illness, based on the prevalence of the disease at Kien Giang General Hospital. An electronic database provided information related to direct medical costs and biochemical parameters, whereas face-to-face interviews with CKD patients were conducted by questionnaire to collect demographic characteristics, direct non-medical costs and indirect costs. The population was divided into three groups based on the stages of CKD including the CKD 1–3 group, CKD 4–5 pre-dialysis group and haemodialysis group. Results: A total of 327 patients were enrolled in the study. Costs varied among three groups of CKD patients. The annual cost per patient in the CKD 1–3 group, CKD 4-5 pre-dialysis group and haemodialysis group were USD 2,826.3 (95%CI: 2,592.3–3,077.1), USD 3,320.3 (95%CI: 2,765.2–3,913.8) and USD 9,498.3 (95%CI: 9,152.5–9,881.4), respectively. Direct medical costs represented the greatest proportion of total costs. The annual cost per patient in the CKD 1–3 group was affected by many characteristics such as age, residence, BMI, education level, exercise and number of comorbidities. In contrast to the CKD 1–3 group, in the haemodialysis group most results were not significantly different in the yearly cost per patient according to demographic and clinical characteristics. Whereas, patients in the CKD 4–5 pre-dialysis group were impacted by factors such as age, residence, occupation and the number of comorbidities. Conclusion: The annual cost per patient in CKD 1–3, CKD 4–5 pre-dialysis and haemodialysis groups were substantial. Patients on haemodialysis incurred the highest cost, about three times compared with the other two groups. The differences in demographic and clinical characteristics affected the annual cost per patient, especially in the CKD 1–3 group.
Authors and Affiliations
Thai Quang Nguyen, Trung Quang Vo, Gia Hon Luu, Nghiem Quan Le
Keywords
Related Articles
- EP ID EP542059
- DOI 10.7860/JCDR/2018/36719.11716
- Views 73
- Downloads 0
A Rare Instance of Levofloxacin Induced Myoclonus
Levofloxacin is a widely used fluoroquinolone, mainly as a respiratory antimicrobial agent. It is employed as a second line therapeutic modality in pulmonary tuberculosis as well. The drug has been in use for ages, and i...
Massive Lymphocytic Infiltration in the Uterus Mimicking Lymphoma-A Potential Diagnostic Challenge
ABSTRACT Leiomyoma with lymphoid infiltration is an uncommon lesion which mimics lymphoma. Although, the polymorphous nature of the lymphoid infiltrate differentiates it from lymphoma, it may pose a diagnostic challenge...
Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis
Introduction: Course of Ulcerative Colitis is characterized by intermittent flares interposed between variable periods of remission. Identification of exacerbating factors and appropriate assessment of disease activity a...
Relation of Vitamin D Supplementation, upto six months of age with Total and Bone Specific Alkaline Phosphatase: A Randomised Control Trial
ABSTRACT Introduction: Vitamin D deficiency is an issue of concern in the Asian population. In the light of the fact that breast milk is an inadequate source of vitamin D, supplementation becomes essential for all term...
Twin Reversed Arterial Perfusion: To Treat or Not?
Acardiac twinning or Twin Reverse Arterial Perfusion (TRAP)-sequence is a rare complication of monochorionic twin pregnancy. Whether to start elective or therapeutic treatment in TRAP-sequence is still controversial. In...